Boston Scientific will end Arthur C. Butcher’s executive role on January 1, 2027, while paying him a prorated $780,000 annual base salary as a senior advisor through February 26. For investors, the transition sets a defined Leadership change while retaining Butcher in an advisory capacity and preserving benefits tied to existing company programs.
Key Highlights
- Butcher communicated his retirement decision to Boston Scientific on September 21.
- His executive departure takes effect on January 1, 2027.
- He is expected to continue as a senior advisor through February 26, 2027, or an earlier Retirement Date.
Butcher’s Executive Role Ends January 1
Butcher communicated his retirement decision to Boston Scientific (NYSE: BSX) on September 21. His executive departure takes effect on January 1, 2027, after which the company expects him to continue as a senior advisor. The arrangement runs through February 26, 2027, or an earlier date if that becomes the Retirement Date.
Retirement Agreement Covers Existing Programs
The agreement is expected to provide payments and benefits materially consistent with those available under the company’s Executive Retirement Plan and 2026 Annual Bonus Plan. The stated terms remain subject to the conditions of those programs.
FAQs
Q: When does Butcher’s executive departure take effect?
A: Butcher communicated his retirement decision to Boston Scientific on September 21. His executive departure takes effect on January 1, 2027.
Q: How long is Butcher expected to continue as a senior advisor?
A: The company expects Butcher to continue as a senior advisor after his executive departure. The advisory arrangement runs through February 26, 2027, or an earlier date if that becomes the Retirement Date.
Q: What does the retirement agreement provide?
A: The agreement is expected to provide payments and benefits materially consistent with the Executive Retirement Plan and 2026 Annual Bonus Plan. Those terms remain subject to the conditions of those programs.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.